articleThe LancetMay 1, 2004Closed access

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

KLKatarina Le BlancIRIda RasmussonBSBerit SundbergCGCecilia GötherströmMHMoustapha Hassan

Karolinska Institutet · Karolinska University Hospital

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

2,731
total citations
FWCI
60.07
Percentile
100%
References
4
Citations per year

Authors

7

Topics & keywords

Topics
Keywords
  • Mesenchymal stem cell
  • Graft-versus-host disease
  • Medicine
  • Stem cell
  • In vivo
  • Bone marrow
  • Immunology
  • Disease
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding